AAM names Karin Hessler assistant general counsel
Karin Hessler has joined the Association for Accessible Medicines as assistant general counsel, effective Tuesday.
“Through her extensive legal representation of manufacturers of generic and biosimilar medicines, Karin will bring valuable insights into the intellectual property barriers that our companies face in trying to deliver safe, more affordable treatment options to patients,” AAM’s senior vice president and general counsel Jeff Francer said.
Hessler will focus primarily on Hatch-Waxman, biosimilar and pharmaceutical patent issues.
Before joining AAM in March 2019, Hessler was a partner at Wiley Rein, where she represented clients on intellectual property matters, with a special focus on patent litigation in the biotechnology and medical device industries. She has played a lead role in all phases of numerous Hatch-Waxman litigations, including expert discovery, fact discovery, claim construction, trials, regulatory analysis and settlement negotiations.
“Through her extensive legal representation of manufacturers of generic and biosimilar medicines, Karin will bring valuable insights into the intellectual property barriers that our companies face in trying to deliver safe, more affordable treatment options to patients,” AAM’s senior vice president and general counsel Jeff Francer said.
Hessler will focus primarily on Hatch-Waxman, biosimilar and pharmaceutical patent issues.
Before joining AAM in March 2019, Hessler was a partner at Wiley Rein, where she represented clients on intellectual property matters, with a special focus on patent litigation in the biotechnology and medical device industries. She has played a lead role in all phases of numerous Hatch-Waxman litigations, including expert discovery, fact discovery, claim construction, trials, regulatory analysis and settlement negotiations.